Pradeep Kumar to Anti-HIV Agents
This is a "connection" page, showing publications Pradeep Kumar has written about Anti-HIV Agents.
Connection Strength
0,637
-
Qualitative and quantitative intravaginal targeting: key to anti-HIV-1 microbicide delivery from test tube to in vivo success. J Pharm Sci. 2012 Jun; 101(6):1950-68.
Score: 0,214
-
Lipid-drug conjugates and associated carrier strategies for enhanced antiretroviral drug delivery. Pharm Dev Technol. 2020 Mar; 25(3):267-280.
Score: 0,092
-
3D printed, controlled release, tritherapeutic tablet matrix for advanced anti-HIV-1 drug delivery. Eur J Pharm Biopharm. 2019 May; 138:99-110.
Score: 0,082
-
Poly(ethylene glycol) enclatherated pectin-mucin submicron matrices for intravaginal anti-HIV-1 drug delivery. Int J Pharm. 2016 Apr 30; 503(1-2):16-28.
Score: 0,071
-
In vivo evaluation of a mucoadhesive polymeric caplet for intravaginal anti-HIV-1 delivery and development of a molecular mechanistic model for thermochemical characterization. Drug Dev Ind Pharm. 2015; 41(8):1274-87.
Score: 0,063
-
Optimization of a polymer composite employing molecular mechanic simulations and artificial neural networks for a novel intravaginal bioadhesive drug delivery device. Pharm Dev Technol. 2012 Jul-Aug; 17(4):407-20.
Score: 0,049
-
In vivo evaluation of the release of zidovudine and polystyrene sulfonate from a dual intravaginal bioadhesive polymeric device in the pig model. J Pharm Sci. 2011 Apr; 100(4):1416-35.
Score: 0,049
-
Design of a novel crosslinked HEC-PAA porous hydrogel composite for dissolution rate and solubility enhancement of efavirenz. Int J Pharm. 2015 Jul 25; 490(1-2):429-37.
Score: 0,017